1. Cerveri I, Accordini S, Corsico A, Zoia MC, Carrozzi L, Cazzoletti L, Beccaria M, Marinoni A, Viegi G, de Marco R. Chronic cough and phlegm in young adults. Eur Respir J. 2003;22:413–7.
2. Mahesh PA, Jayaraj BS, Prabhakar AK, Chaya SK, Vijayasimha R. Prevalence of chronic cough, chronic phlegm & associated factors in Mysore, Karnataka, India. Indian J Med Res. 2011;134:91–100.
3. Okayama Y, Kawayama T, Kinoshita T, Tokunaga Y, Sasaki J, Sakazaki Y, Imaoka H, Hoshino T. Impact of airfow obstruction on long-term mortality in patients with asthma in Japan. Allergol Int. 2019;68:462–9.
4. Lee BR, Kim YI, Kim S, Lee HS, Yoon SH, Yu JY, Ban HJ, Kwon YS, Oh IJ, Kim KS, et al. Prevalence of chronic sputum and associated factors in Korean adults. J Korean Med Sci. 2014;29:825–30.
5. Lee AL, Goldstein RS. Gastroesophageal refux disease in COPD: links and risks. Int J Chron Obstruct Pulmon Dis. 2015;10:1935–49.
6. Hasegawa K, Sato S, Tanimura K, Fuseya Y, Uemasu K, Hamakawa Y, Sato A, Mishima M, Muro S, Hirai T. Gastroesophageal refux symptoms and nasal symptoms afect the severity of bronchitis symptoms in patients with chronic obstructive pulmonary disease. Respir Investig. 2018;56:230–7.
7. Greulich T, Weist BJD, Koczulla AR, Janciauskiene S, Klemmer A, Lux W, Alter P, Vogelmeier CF. Prevalence of comorbidities in COPD patients by disease severity in a German population. Respir Med. 2017;132:132–8.
8. Tay TR, Hew M. Comorbid “treatable traits” in difcult asthma: current evidence and clinical evaluation. Allergy. 2018;73:1369–82.
9. Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. J Allergy Clin Immunol. 2007;119:405–13.
10. Cheung TK, Lam B, Lam KF, Ip M, Ng C, Kung R, Wong BCY. Gastroesophageal refux disease is associated with poor asthma control, quality of life, and psychological status in Chinese asthma patients. Chest. 2009;135:1181–5.
11. Nordenstedt H, Nilsson M, Johansson S, Wallander MA, Johnsen R, Hveem K, Lagergren J. The relation between gastroesophageal refux and respiratory symptoms in a population-based study: the Nord-Trondelag health survey. Chest. 2006;129:1051–6.
12. Niimi A. Cough associated with gastro-oesophageal refux disease (GORD): Japanese experience. Pulm Pharmacol Ther. 2017;47:59–65.
13. Fontana GA, Pistolesi M. Cough. 3: chronic cough and gastro-oesophageal refux. Thorax. 2003;58:1092–5.
14. Matsumoto H, Izuhara Y, Niimi A, Tabara Y, Nagasaki T, Kanemitsu Y, Murase K, Oguma T, Ito I, Muro S, et al. Risks and cough-aggravating factors in prolonged cough. Epidemiological observations from the Nagahama cohort study. Ann Am Thorac Soc. 2017;14:698–705.
15. Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, Kuribayashi S, Higuchi T, Zai H, Ino K, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888–91.
16. Kusano M, Hosaka H, Kawada A, Kuribayashi S, Shimoyama Y, Kawamura O, Moki F. Development and evaluation of a modifed Frequency Scale for the Symptoms of Gastroesophageal Refux Disease to distinguish functional dyspepsia from non-erosive refux disease. J Gastroenterol Hepatol. 2012;27:1187–91.
17. Yasaka S, Murakami K, Abe T, Anan J, Mizukami K, Tanahashi J, Okimoto T, Kodama M, Kudo Y, Kawasaki H, Fujioka T. Evaluation of esophageal function in patients with gastroesophageal refux disease using transnasal endoscopy. J Gastroenterol Hepatol. 2009;24:1677–82.
18. Enright PL, Kronmal RA, Higgins MW, Schenker MB, Haponik EF. Prevalence and correlates of respiratory symptoms and disease in the elderly. Chest. 1994;106:827–34.
19. Ing AJ, Ngu MC, Breslin AB. Pathogenesis of chronic persistent cough associated with gastroesophageal refux. Am J Respir Crit Care Med. 1994;149:160–7.
20. Cui YY, Zhu L, Wang H, Advenier C, Chen HZ, Devillier P. Muscarinic receptors involved in airway vascular leakage induced by experimental gastro-oesophageal refux. Life Sci. 2008;82:949–55.
21. Cui Y, Devillier P, Kuang X, Wang H, Zhu L, Xu Z, Xia Z, Zemoura L, Advenier C, Chen H. Tiotropium reduction of lung infammation in a model of chronic gastro-oesophageal refux. Eur Respir J. 2010;35:1370–6.
22. Roberts NJ, Lloyd-Owen SJ, Rapado F, Patel IS, Wilkinson TMA, Donaldson GC, Wedzicha JA. Relationship between chronic nasal and respiratory symptoms in patients with COPD. Respir Med. 2003;97:909–14.
23. Iwakiri K, Kinoshita Y, Habu Y, Oshima T, Manabe N, Fujiwara Y, Nagahara A, Kawamura O, Iwakiri R, Ozawa S, et al. Evidence-based clinical practice guidelines for gastroesophageal refux disease 2015. J Gastroenterol. 2016;51:751–67.
24. Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44:518–34.
25. Danjo A, Yamaguchi K, Fujimoto K, Saitoh T, Inamori M, Ando T, Shimatani T, Adachi K, Kinjo F, Kuribayashi S, et al. Comparison of endoscopic fndings with symptom assessment systems (FSSG and QUEST) for gastroesophageal refux disease in Japanese centres. J Gastroenterol Hepatol. 2009;24:633–8.
26. El-Serag HB. Epidemiology of non-erosive refux disease. Digestion. 2008;78(Suppl 1):6–10.
27. Kanemitsu Y, Niimi A, Matsumoto H, Iwata T, Ito I, Oguma T, Inoue H, Tajiri T, Nagasaki T, Izuhara Y, et al. Gastroesophageal dysmotility is associated with the impairment of cough-specifc quality of life in patients with cough variant asthma. Allergol Int. 2016;65:320–6.